Table 1 Baseline characteristics of cases and controls.
From: The UF-5000 Atyp.C parameter is an independent risk factor for bladder cancer
Data | Cases (n = 473) | Controls (n = 473) | P value |
|---|---|---|---|
Gender n (%) | |||
Male | 357 (75.4%) | 357 (75.4%) | > 0.5 |
Female | 116 (24.6%) | 116 (24.6%) | > 0.5 |
Age, years | |||
Median (IQR) | 67 (59, 75) | 67 (59, 75) | > 0.5 |
Blandder cancer n (%) | |||
The first clinical diagnosis | 314 (66.4%) | ||
The new recurrence | 154 (33.6%) | ||
Results of urine sediment | |||
Atyp.C (Median (IQR)) /ul | 0.2 (0, 0.9) | 0 (0, 0.1) | 0.000 |
N.SEC (Median (IQR))/ul | 4.1 (1.4, 10.6) | 2.3 (0.9, 5.8) | 0.000 |
SEC (Median (IQR))/ul | 6.9 (2.4, 17.8) | 4.4 (1.6, 10.0) | 0.000 |
WBC (Median (IQR))/ul | 88.2 (19.4, 311.7) | 50.6 (8.3, 301.8) | 0.02 |
Results of dipstick urinalysis | |||
BLD n (%) | |||
BLD (−) | 70 (14.8%) | 138 (29.2%) | |
BLD (±) | 39 (8.2%) | 62 (13.1%) | |
BLD (1+) | 57 (12.1%) | 72 (15.2%) | |
BLD (2+) | 45 (9.5%) | 65 (13.7%) | |
BLD (3+) | 262 (55.4%) | 136 (28.8%) | |
LEU n (%) | |||
LEU (−) | 212 (44.8%) | 196 (41.4%) | |
LEU (±) | 41 (8.7%) | 28 (5.9%) | |
LEU (1+) | 75 (15.9%) | 80 (16.9%) | |
LEU (2+) | 62 (13.1%) | 57 (12.1%) | |
LEU (3+) | 83 (17.5%) | 112 (23.7%) | |
PRO n (%) | |||
PRO (−) | 160 (33.8%) | 264 (55.8%) | |
PRO (±) | 90 (19%) | 79 (16.7%) | |
PRO (1+) | 94 (19.9%) | 70 (14.8%) | |
PRO (2+) | 85 (18%) | 40 (8.5%) | |
PRO (3+) | 44 (9.3%) | 20 (4.2%) | |
Col n (%) | |||
Yellow | 378 (79.9%) | 443 (93.7%) | |
Other | 95 (20.1%) | 30 (6.3%) | |
CLA n (%) | |||
Clear | 312 (66.0%) | 373 (78.9%) | |
Cloudy | 161 (20.1%) | 100 (21.1%) | |
